Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 4
2006 4
2007 2
2008 1
2009 1
2010 1
2011 1
2012 1
2013 5
2014 5
2015 10
2016 8
2017 12
2018 10
2019 5
2020 7
2021 16
2022 10
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
CD8+ T-cell Responses Are Boosted by Dual PD-1/VEGFR2 Blockade after EGFR Inhibition in Egfr-Mutant Lung Cancer.
Nishii K, Ohashi K, Tomida S, Nakasuka T, Hirabae A, Okawa S, Nishimura J, Higo H, Watanabe H, Kano H, Ando C, Makimoto G, Ninomiya K, Kato Y, Kubo T, Ichihara E, Hotta K, Tabata M, Toyooka S, Udono H, Maeda Y, Kiura K. Nishii K, et al. Among authors: kato y. Cancer Immunol Res. 2022 Sep 1;10(9):1111-1126. doi: 10.1158/2326-6066.CIR-21-0751. Cancer Immunol Res. 2022. PMID: 35802887 Free article.
Transformed diffuse large B-cell lymphoma from marginal zone lymphoma in the anterior mediastinum: A case report and review of the literature.
Kitamura W, Asada N, Tabata T, Shibata R, Nishi T, Kato Y, Takasuka H, Fujiwara H, Ennishi D, Nishimori H, Fujii N, Matsuoka KI, Kiura K, Yoshino T, Maeda Y. Kitamura W, et al. Among authors: kato y. J Clin Exp Hematop. 2022 Mar 9;62(1):35-40. doi: 10.3960/jslrt.21010. Epub 2021 Nov 26. J Clin Exp Hematop. 2022. PMID: 34840205 Free PMC article. Review.
Anxiety Impacts Consent Capacity to Treatment in Alzheimer's Disease.
Kato Y, Matsuoka T, Eguchi Y, Iiboshi K, Koumi H, Nakamura K, Okabe K, Nakaaki S, Furukawa TA, Mimura M, Narumoto J. Kato Y, et al. Front Psychol. 2021 Jun 14;12:685430. doi: 10.3389/fpsyg.2021.685430. eCollection 2021. Front Psychol. 2021. PMID: 34194376 Free PMC article.
Magnitude of the benefit of progression-free survival as a potential surrogate marker in phase 3 trials assessing targeted agents in molecularly selected patients with advanced non-small cell lung cancer: systematic review.
Hotta K, Kato Y, Leighl N, Takigawa N, Gaafar RM, Kayatani H, Hirata T, Ohashi K, Kubo T, Tabata M, Tanimoto M, Kiura K. Hotta K, et al. Among authors: kato y. PLoS One. 2015 Mar 16;10(3):e0121211. doi: 10.1371/journal.pone.0121211. eCollection 2015. PLoS One. 2015. PMID: 25775395 Free PMC article. Review.
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801.
Hosokawa S, Ichihara E, Harada D, Kuyama S, Inoue K, Gemba K, Ichikawa H, Kato Y, Oda N, Oze I, Tamura T, Kozuki T, Umeno T, Kubo T, Hotta K, Bessho A, Maeda Y, Kiura K. Hosokawa S, et al. Among authors: kato y. Int J Clin Oncol. 2022 Jul;27(7):1139-1144. doi: 10.1007/s10147-022-02164-2. Epub 2022 May 10. Int J Clin Oncol. 2022. PMID: 35534642 Clinical Trial.
δ Scores are Exportable Across Cultural and Linguistic Boundaries.
Royall DR, Palmer RF, Matsuoka T, Kato Y, Taniguchi S, Ogawa M, Fujimoto H, Okamura A, Shibata K, Nakamura K, Nakaaki S, Koumi H, Mimura M, Fukui K, Narumoto J. Royall DR, et al. Among authors: kato y. J Alzheimers Dis. 2016;49(2):561-70. doi: 10.3233/JAD-150261. J Alzheimers Dis. 2016. PMID: 26444764
102 results